Ugur Sahin
$3.97B
$34.8M (-0.9%)
as of 08/10/26
About Ugur Sahin
Uğur Şahin is CEO and cofounder of German biotech firm BioNTech, which partnered with Pfizer to produce the first Covid-19 vaccine approved in the US.
Şahin led BioNTech to start on a vaccine for the coronavirus in early 2020; it partnered with Pfizer in March 2020 and got approval in December.
Şahin, who was born in Turkey and grew up in Germany, owns about 17% of BioNTech, which went public on the Nasdaq in October 2019.
In 2001 Şahin and his immunologist wife, ?zlem T'reci, cofounded Ganymed Pharmaceuticals; Astellas Pharma acquired Ganymed in 2016 for $460 million.
Şahin and his wife T'reci cofounded BioNTech in 2008, backed by German billionaire brothers Thomas and Andreas Struengmann.
Personal stats
Citizenship
GermanySource of wealth
BiotechnologyResidence
MainzMarital status
MarriedBirth date
09/19/65 (age 60)Self-made
self-madeUgur Sahin’s fortune is worth
66K
troy ounces of gold
61K
median U.S. household
40K
median U.S. income
0.079%
U.S. credit card volume
0.016%
GDP of the United States
0.012%
United States debt
Net worth history
Annual ranking
Related people
Did you know?
Germany's billionaire Struengmann brothers have backed both of Sahin's drug companies: Ganymed Pharmaceuticals and BioNTech SE.
Net worth over time
Real-time ranking
Financial assets
NASDAQ | BNTX-US
BioNTech Sponsored ADRImages © Forbes.com. All rights reserved.